Unlike bacterial and fungal meningitis in which imaging abnormalities are not specific for a particular agent, many virus infections of the CNS produce MRI abnormalities not seen by any other infectious agent. The changes caused by the specific virus can also be produced by noninfectious disorders. Imaging changes must always be evaluated in conjunction with the clinical symptoms, signs, and laboratory abnormalities, particularly the presence of a CSF pleocytosis. The purpose of this montage is to ensure that the clinician includes the specific virus in the differential diagnosis (figure).
Figure
Brain imaging abnormalities in CNS virus infections Characteristic abnormalities are brain atrophy and diffuse white matter attenuation. Differential diagnosis includes long-standing hypertension, chemotherapy, or X-irradiation; in the latter three conditions, the extent of the white matter abnormalities usually exceeds the degree of brain atrophy. (F) JC virus infection of the CNS causes progressive multifocal leukoencephalopathy. Typical multifocal and confluent subcortical nonenhancing white matter hyperintensities extending to the cortical gray matter. Differential diagnosis includes CNS lymphoma, glioma, disseminated encephalomyelitis, sarcoidosis exclusively in white matter, chemotherapy, and X-irradiation. (G) Acute disseminated or postinfectious encephalomyelitis after virus infection. Subcortical white matter lesions (short arrow) involving subcortical U fibers with tangential lesions (long arrow). Differential diagnosis includes disorders listed in F. Brain imaging is frequently normal in viral encephalitis. Occasionally, nonspecific changes consist of either sulcal effacement (H) (thin arrow), compared with normal sulcal spaces (thick arrow); or increased signal (I) (arrow), reflecting increased water content in the mildly swollen brain of the same patient. These changes developed in a patient with probable enterovirus encephalitis but can be produced by many viruses, as well as after head injury and in various metabolic encephalopathies.
